The transaction, announced on 31 July, remained subject to closing conditions and regulatory and exchange approvals, with completion expected during August.
Life insurance growth remained subdued in H1, while health and non-motor business supported gains in the non-life sector amid sweeping regulatory changes.
The Taiwan reinsurer’s domestic life book continued to expand, while retained profit increased adjusted capital and surplus into the first quarter of 2026.
The insurer registered a 102.5% combined ratio in 2025, though AM Best expects growth in Korea Interests Abroad and affiliate business to support future results.
Aggressive pricing and weak solvency among several state-owned insurers could test India's insurance growth story despite favourable regulatory reforms, S&P says.
